The Microbiome in Dermatology: Hype, Hope, or Future Standard of Care? Review Abstract The human skin microbiome has emerged as a critical factor in dermatological health and disease. This paper examines the current state of microbiome research in dermatology, evaluating whether the field represents scientific
Dermatology
Skin of Color Dermatology: Why Current Medical Guidelines Are Leaving Patients Behind
Skin of Color Dermatology: Why Current Medical Guidelines Are Leaving Patients Behind Review Key Takeaways Contemporary dermatology practice continues to demonstrate significant limitations in the diagnosis and management of conditions in patients with darker skin tones, contributing to measurable disparities in clinical outcomes. As individuals
Cosmeceuticals vs Prescription Therapy: Where Does Science End and Marketing Begin?
Cosmeceuticals vs Prescription Therapy: Where Does Science End and Marketing Begin? Review Abstract The distinction between cosmeceuticals and prescription dermatologic therapies has become progressively less defined, creating a complex therapeutic landscape for clinicians and patients. Cosmeceuticals are commonly described as topical products that occupy an
The Explosion of At-Home Dermatology Significant Threat or Opportunity?
The Explosion of At-Home Dermatology Significant Threat or Opportunity Abstract The rapid expansion of at home dermatology devices has generated significant interest within both consumer markets and the medical community. Over the past decade, advances in miniaturized technology, digital connectivity, and consumer health awareness have driven the
New Treatments for Atopic Dermatitis in 2026: Why More Options Might Be Making Your Choice Harder
New Treatments for Atopic Dermatitis in 2026 Why More Options Might Be Making Your Choice Harder Key Takeaways The treatment landscape for atopic dermatitis has changed profoundly over the past several years, moving from a limited set of broadly acting immunosuppressive therapies to an increasingly sophisticated range
Alopecia Areata News: New Immune Therapies Challenge Steroid-Only Treatment Approach
Alopecia Areata News: New Immune Therapies Challenge Steroid-Only Treatment Approach Key Takeaways The alopecia areata treatment landscape has transformed dramatically, moving beyond ineffective steroid-only approaches to targeted immune therapies that offer real hope for patients with severe hair loss. Three FDA-approved JAK inhibitors are
Beyond Psoriasis: Why Biologics Are Reshaping Disease-Specific Dermatology
Beyond Psoriasis: Why Biologics Are Reshaping Disease-Specific Dermatology Introduction Biologics have transformed the therapeutic landscape of chronic inflammatory dermatoses, demonstrating remarkable efficacy and safety profiles in conditions previously challenging to manage. These targeted immunomodulators have revolutionized treatment approaches for moderate-to-severe psoriasis, hidradenitis suppurativa,
Remote Rheumatology: Can Telehealth Accurately Assess Joint Activity and Skin Disease?
Remote Rheumatology Can Telehealth Accurately Assess Joint Activity and Skin Disease Check out our extensive video library (see channel for our latest videos) Abstract Purpose:This study evaluates the effectiveness of telehealth platforms in the assessment of rheumatologic conditions, with a specific focus on joint activity and
Revisiting Lyme Disease Management in Primary Care
Revisiting Lyme Disease Management in Primary Care: Evidence-Based Approaches for Contemporary Practice Abstract Lyme disease represents a significant diagnostic and therapeutic challenge in primary care medicine, particularly in endemic regions across North America and Europe. This comprehensive review examines current evidence-based approaches to Lyme disease
The Surprising Link Between Psoriasis and Heart Disease: What Patients Need to Know
The Surprising Link Between Psoriasis and Heart Disease: What Patients Need to Know Introduction Psoriasis and cardiovascular disease are closely connected in ways that extend well beyond coincidental comorbidity. Psoriasis affects approximately 2 to 3 percent of the U.S. population, and individuals with this chronic inflammatory
